GFM
NGNE icon

GF Fund Management’s Neurogene NGNE Stock Holding History

GF Fund Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.85K Buy
340
+38
+13% +$736 ﹤0.01% 587
2025
Q4 		$6.22K Sell
302
-14
-4% -$348 ﹤0.01% 610
2025
Q3 		$5.48K Sell
316
-52
-14% -$1.04K ﹤0.01% 605
2025
Q2 		$5.5K Hold
368
– – ﹤0.01% 620
2025
Q1 		$4.31K Buy
368
+56
+18% +$973 ﹤0.01% 630
2024
Q4 		$7.13K Buy
+312
New +$11.6K ﹤0.01% 585

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

GF Fund Management's NGNE Position: Q1 2026 in Review

GF Fund Management increased its Neurogene (NGNE) stake by 13% in Q1 2026, buying an estimated $736 and bringing the position to 340 shares worth $6.85K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

GF Fund Management first reported a position in NGNE in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.13K in Q4 2024. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • GF Fund Management held 340 shares of Neurogene worth $6.85K as of Q1 2026.
  • GF Fund Management bought 38 Neurogene shares in Q1 2026, an estimated $736.
  • Neurogene made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #587 holding.
  • GF Fund Management first reported a position in Neurogene in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Neurogene position peaked at $7.13K in Q4 2024.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.